Low Dose Melphalan Is a Treatment Option in Elderly Patients With High Risk Myelodysplastic Syndrome or Secondary Acute Myeloblastic Leukaemia
Haematologia
doi 10.1163/156855902320388023
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2002
Authors
Publisher
Brill